BIOMAT Database Logo BIOMAT Database Logo

[Use of thymalin in treating severe forms of inflammatory diseases of the maxillofacial area]. 1984

M M Solov'ev, and T M Alekhova, and I I Grintsevich, and B G Golubev, and V G Morozov

UI MeSH Term Description Entries
D008297 Male Males
D008336 Mandibular Diseases Diseases involving the MANDIBLE. Disease, Mandibular,Diseases, Mandibular,Mandibular Disease
D010403 Penicillin Resistance Nonsusceptibility of an organism to the action of penicillins. Penicillin Resistances,Resistance, Penicillin,Resistances, Penicillin
D010406 Penicillins A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065) Antibiotics, Penicillin,Penicillin,Penicillin Antibiotics
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005145 Face The anterior portion of the head that includes the skin, muscles, and structures of the forehead, eyes, nose, mouth, cheeks, and jaw. Faces
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections

Related Publications

M M Solov'ev, and T M Alekhova, and I I Grintsevich, and B G Golubev, and V G Morozov
[Combined treatment of suppurative inflammatory diseases of the maxillofacial area using thymalin].
October 1981, Vestnik khirurgii imeni I. I. Grekova,
M M Solov'ev, and T M Alekhova, and I I Grintsevich, and B G Golubev, and V G Morozov
[The use of the Uzor laser apparatus for treating inflammatory diseases of the maxillofacial area].
January 1989, Stomatologiia,
M M Solov'ev, and T M Alekhova, and I I Grintsevich, and B G Golubev, and V G Morozov
[Clinico-physiologic characteristics of intravenous sombrevin anesthesia in treating inflammatory diseases of the maxillofacial area].
January 1990, Stomatologiia,
M M Solov'ev, and T M Alekhova, and I I Grintsevich, and B G Golubev, and V G Morozov
[Means of decreasing complications in patients with severe inflammatory diseases of the maxillofacial area].
January 1987, Stomatologiia,
M M Solov'ev, and T M Alekhova, and I I Grintsevich, and B G Golubev, and V G Morozov
[Use of thymalin in treating periodontitis patients].
January 1985, Stomatologiia,
M M Solov'ev, and T M Alekhova, and I I Grintsevich, and B G Golubev, and V G Morozov
[Use of glucocorticoids in patients with acute odontogenic inflammatory diseases of the maxillofacial area].
January 1977, Stomatologiia,
M M Solov'ev, and T M Alekhova, and I I Grintsevich, and B G Golubev, and V G Morozov
[Lipid peroxidation in suppurative-inflammatory diseases of the maxillofacial area].
January 1992, Stomatologiia,
M M Solov'ev, and T M Alekhova, and I I Grintsevich, and B G Golubev, and V G Morozov
[The therapy of inflammatory diseases of the maxillofacial area with the use of imidazole derivatives].
January 1992, Stomatologiia,
M M Solov'ev, and T M Alekhova, and I I Grintsevich, and B G Golubev, and V G Morozov
[The clinico-experimental validation of carbon sorption drainage in treating suppurative-inflammatory diseases of the maxillofacial area in children].
January 1991, Stomatologiia,
M M Solov'ev, and T M Alekhova, and I I Grintsevich, and B G Golubev, and V G Morozov
[Biochemical tests for diagnosing inflammatory diseases of the maxillofacial area].
June 1980, Stomatologiia,
Copied contents to your clipboard!